Reply to: "Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action"

J Hepatol. 2020 Mar;72(3):585-586. doi: 10.1016/j.jhep.2019.11.010. Epub 2019 Dec 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Africa South of the Sahara / epidemiology
  • Antiviral Agents* / therapeutic use
  • Genotype
  • Hepatitis C* / drug therapy
  • Hepatitis C, Chronic* / drug therapy
  • Humans

Substances

  • Antiviral Agents